Physics design point of high-field stellarator reactors
Authors:
J. A. Alonso,
I. Calvo,
D. Carralero,
J. L. Velasco,
J. M. García-Regaña,
I. Palermo,
D. Rapisarda
Abstract:
The ongoing development of electromagnets based on High Temperature Superconductors has led to the conceptual exploration of high-magnetic-field fusion reactors of the tokamak type, operating at on-axis fields above 10 T. In this work we explore the consequences of the potential future availability of high-field three-dimensional electromagnets on the physics design point of a stellarator reactor.…
▽ More
The ongoing development of electromagnets based on High Temperature Superconductors has led to the conceptual exploration of high-magnetic-field fusion reactors of the tokamak type, operating at on-axis fields above 10 T. In this work we explore the consequences of the potential future availability of high-field three-dimensional electromagnets on the physics design point of a stellarator reactor. We find that, when an increase in the magnetic field strength $B$ is used to maximally reduce the device linear size $R\sim B^{-4/3}$ (with otherwise fixed magnetic geometry), the physics design point is largely independent of the chosen field strength/device size. A similar degree of optimization is to be imposed on the magnetohydrodynamic, transport and fast ion confinement properties of the magnetic configuration of that family of reactor design points. Additionally, we show that the family shares an invariant operation map of fusion power output as a function of the auxiliary power and relative density variation. The effects of magnetic field over-engineering and the $R(B)$ scaling of design points with constant neutron wall loading are also inspected. In this study we use geometric parameters characteristic of the helias reactor, but most results apply to other stellarator configurations
△ Less
Submitted 25 December, 2021; v1 submitted 30 September, 2021;
originally announced September 2021.
Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies
Authors:
Paolo Fagone,
Rosella Ciurleo,
Salvo Danilo Lombardo,
Carmelo Iacobello,
Concetta Ilenia Palermo,
Yehuda Shoenfeld,
Klaus Bendtzen,
Placido Bramanti,
Ferdinando Nicoletti
Abstract:
The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) has posed a serious threat to global health. As no specific therapeutics are yet available to control disease evolution, more in-depth understanding of the pathogenic mechanisms induced by SARS-CoV-2 will help to characterize new targets for the management of COVID-19. The present study identified…
▽ More
The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) has posed a serious threat to global health. As no specific therapeutics are yet available to control disease evolution, more in-depth understanding of the pathogenic mechanisms induced by SARS-CoV-2 will help to characterize new targets for the management of COVID-19. The present study identified a specific set of biological pathways altered in primary human lung epithelium upon SARS-CoV-2 infection, and a comparison with SARS-CoV from the 2003 pandemic was studied. The transcriptomic profiles were also exploited as possible novel therapeutic targets, and anti-signature perturbation analysis predicted potential drugs to control disease progression. Among them, Mitogen-activated protein kinase kinase (MEK), serine-threonine kinase (AKT), mammalian target of rapamycin (mTOR) and I kappa B Kinase (IKK) inhibitors emerged as candidate drugs. Finally, sex-specific differences that may underlie the higher COVID-19 mortality in men are proposed.
△ Less
Submitted 3 May, 2020;
originally announced May 2020.
